Back to search
Driving Under the Influence
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Driving Under the Influence trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Driving Under the Influence trials you may qualify forCo-administration of cannabis and tobacco is a common practice, but there is little experimental evidence aimed at understanding the reasons for this prevalence…
The goal of this clinical trial is to evaluate whether in-vehicle sensor data can be used to detect cannabis-impaired driving in healthy adult recreational cann…
The relevance of driving under the influence of cannabis is becoming increasingly important in the context of legalization. However, the measurement of tetrahyd…
Bladder cancer is a prevalent malignancy globally, with muscle-invasive disease having a five-year survival rate below 50%. Neoadjuvant chemotherapy (NAC) befor…
According to the Centers for Disease Control and Prevention (CDC), "88,000 people die every year due to alcohol-related issues including homicide, sexual assaul…
The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. S…
The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.
The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.
The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.